This issue brief provides a primer on FDA user fees, presents findings of how user fees affect the cost of medical product development, and summarizes the research literature on user fees, most notably in expediting medical product development and approval.
Public Health
Access up-to-date ASPE research on key public health topics including emerging and re-emerging infectious diseases, such as influenza and COVID-19; health equity; antibiotic resistance; rural health; opioids, opioid use disorder and overdose prevention; maternal health; public health and health care workforce and infrastructure; immunization and vaccines; Indian health; HIV/AIDS; tobacco; and emergency preparedness, response, and recovery. Also find data on prevention, social determinants of health, and more.
Noteworthy
HHS Initiative to Improve Maternal Health
The Department’s Action Plan lays out a vision for improving maternal health that applies a “life course” approach organized around four goals and it sets three ambitious targets to achieve this vision. Each of the four goals includes multiple objectives and action items to drive progress. The Action Plan also describes the current state of maternal health outcomes in the U.S., challenges in reducing maternal mortality and morbidity, recent efforts to improve maternal health within and beyond the federal government, and it discusses various forums in which HHS leadership sought input from key stakeholders.
Reports
Displaying 91 - 100 of 955. 10 per page. Page 10.
Advanced SearchASPE Issue Brief
FDA User Fees: Examining Changes in Medical Product Development and Economic Benefits
ASPE Issue Brief
COVID-19 Vaccine Hesitancy and Reasons for Hesitancy Among Essential and Non-Essential Workers
Using 2021-2022 survey data from the U.S. Census Bureau’s Household Pulse Survey, this ASPE Research Report examined sociodemographic factors and trends in vaccine hesitancy among workers based on the likelihood of exposure risk to SARS-CoV-2. We classified work setting into three categories: essential healthcare, essential non-healthcare, and non-essential.
ASPE Issue Brief
Inflation Reduction Act Research Series: Medicare Part D Enrollee Savings from Elimination of Vaccine Cost-Sharing
Effective January 1, 2023, the Inflation Reduction Act (IRA) eliminated enrollee cost-sharing for recommended vaccines covered under Medicare Part D. In 2021, 3.4 million people received vaccines under Part D, and annual out-of-pocket costs were $234 million.
ASPE Issue Brief
Advancing Primary Prevention in Human Services: Convening Findings
This brief highlights key themes and ideas from a Health and Human Services (HHS) Convening on Advancing Primary Prevention in Human Services in August 2022. With a particular focus on prevention of youth and family homelessness, the convening featured the perspectives of academic experts, program administrators, federal colleagues, and people with lived expertise.
ASPE Issue Brief
Children’s Health Coverage Trends: Gains in 2020-2022 Reverse Previous Coverage Losses
This Issue Brief examines children’s health coverage trends using the National Health Interview Survey from 2010 through the third quarter of 2022 and reviews recent research findings from the National Survey of Children's Health on children’s access to and utilization of health care services during this period, including the COVID-19 pandemic.
Report
Factors Contributing to Reductions in Patient Wait Times at Indian Health Service Emergency Department Facilities: A Mixed-Methods Assessment
This ASPE Research Report summarizes findings about factors affecting Emergency Department wait times and Primary Care appointment scheduling intervals, and it describes strategies Indian Health Service (IHS) federal facilities have implemented associated with decreased wait times in Emergency Departments.Available Reports:
Report to Congress
Health Care Transitions for Individuals Returning to the Community from a Public Institution: Promising Practices Identified by the Medicaid Reentry Stakeholder Group
This report summarizes the identified practices of the Medicaid Reentry Stakeholder Group and, as required by Section 5032 of the SUPPORT Act, informs design of a demonstration opportunity “under Section 1115 of the Social Security Act (42 U.S.C.
ASPE Data Point
Insulin Affordability and the Inflation Reduction Act: Medicare Beneficiary Savings by State and Demographics
Effective January 1, 2023, out-of-pocket costs for insulin are capped at $35 per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act (IRA). A similar cap takes effect in Medicare Part B on July 1, 2023.
Policy Brief
Linking Child Welfare and Medicaid Data: Lessons Learned from Two States
This report provides information to state, tribal, and local child welfare and behavioral health agencies that are interested in linking their Medicaid and child welfare data.
ASPE Issue Brief
COVID-19 Antivirals Utilization: Geographic and Demographic Patterns of Treatment in 2022
This report examines the utilization of oral antiviral medications, Paxlovid and Lagevrio, for the treatment of COVID-19. The analyses include an examination of time trends of COVID-19 antiviral use as well as breakdowns by age cohorts and gender. The report finds that utilization in the U.S.